��Թ� News - William Foulkes

‘Jumping gene’ helps explain elevated pancreatic cancer risk in French-Canadians

webfull — Tue, 19 May 2026 14:13:42 +0000

Researchers at ��Թ� have discovered a centuries-old genetic mutation that helps to explain why some French‑Canadians in Quebec are at an elevated risk of pancreatic cancer. Until quite recently, standard genetic tests have not been able to identify this “jumping gene” cause.

The findings, published in the Journal of Medical Genetics, suggest better-targeted genetic testing could help identify people at higher cancer risk who were previously missed.

Published: 19 May 2026

Common hereditary cancer mutation in Quebec traced to single ancestor

webfull — Thu, 17 Jul 2025 18:17:28 +0000

Researchers have shed new light on the most common genetic variant linked to hereditary cancer in Quebec’s French-Canadian population. Their findings could result in cheaper and more effective screening methods.

The variant is associated with Lynch syndrome, a condition that greatly increases the risk of colorectal and other cancers.

Published: 17 July 2025

Experts: Cancer screening guidelines

webfull — Thu, 19 Jun 2025 14:20:37 +0000

The federal government is expected to overhaul Canada’s cancer screening task force following criticism that its recommendations are outdated and lacked expert input. Breast cancer screening is a key focus, with growing pressure to lower the starting age to 40.

��Թ� experts are available to speak to the debate, including:

Published: 19 June 2025

Universal genetic testing of breast cancer patients could help many

webfull — Mon, 09 Dec 2024 13:48:35 +0000

A new study demonstrates how universal genetic testing for breast cancer can ensure no patient is missed for advanced therapies.

Published: 9 December 2024

Shared genetic marker offers new promise in targeting specific ovarian and lung cancers

webfull — Mon, 04 Feb 2019 15:52:24 +0000

Two new papers, published simultaneously in Nature Communications and led by researchers at ��Թ�, offer promise that a drug currently used to treat estrogen positive breast cancer may be effective in treating two different types of cancer, one rare and one common form.

Published: 4 February 2019

Searching for the “signature” causes of BRCAness in breast cancer

webfull — Tue, 22 Aug 2017 14:18:49 +0000

By Tom Ulrich from the Broad Institute

Published: 22 August 2017

Limiting genetic tests for breast cancer susceptibility

webfull — Mon, 01 Jun 2015 20:26:05 +0000

Screening for genes whose risk association with breast cancer has yet to be proven is not justified and potentially harmful, argue an international team of leading geneticists and oncologists in a paper published this week in the prestigious New England Journal of Medicine.

Published: 1 June 2015

New breast cancer gene identified

webfull — Mon, 27 Apr 2015 18:04:50 +0000

Published: 27 April 2015

���������Թ� News - William Foulkes